Surgery – Diagnostic testing
Reexamination Certificate
2000-03-28
2003-09-02
Winakur, Eric F. (Department: 3736)
Surgery
Diagnostic testing
C600S554000, C607S040000, C607S133000, C128S898000
Reexamination Certificate
active
06612983
ABSTRACT:
BACKGROUND OF THE INVENTION
This disclosure relates to a medical test and more specifically to a test protocol for assessing a patient's pancreatic response to natural and electrical stimulation.
The medical device industry produces a wide variety of electronic and mechanical devices for treating patient medical conditions. Depending upon medical condition, medical devices can be surgically implanted or connected externally to the patient receiving treatment. Clinicians use medical devices alone or in combination with drug therapies and surgery to treat patient medical conditions. For some medical conditions, medical devices provide the best, and sometimes the only, therapy to restore an individual to a more healthful condition and a fuller life. One type of medical device that can be used to treat pancreatic conditions is a neurostimulator. Neurostimulator treatment for pancreatic conditions involves placing electrical leads typically within the gastrointestinal tract of a patient and applying an electrical signal with an implanted or external neurostimulator. When considering whether neurostimulation would be suitable to treat a condition in a patient, patient testing is helpful.
Pancreatic testing is challenging because the pancreas is a complex organ with a multitude of functions and many pancreatic conditions manifest themselves indirectly through symptoms that may not initially be attributed to a pancreatic condition. Pancreatic testing is also challenging because the pancreas is not a static organ that secretes at a constant rate. Pancreatic secretion varies in response to a variety of factors that may stimulate or decrease pancreatic secretions. Some conditions attributable to pancreatic dysfunction are: pancreatitis, diabetes, inflammation of the pancreas, malabsorbtion syndrome, and certain cancers. In addition to these conditions, there are a variety of other conditions that may be attributable to pancreatic dysfunction such as pain, nausea, and vomiting.
Previous pancreatic diagnostic tests are static and involve measuring one or more pancreatic function indicators and then correlating the measurements to measurements expected for various types of pancreatic disease. An example such static pancreatic testing is described in the following publication: Frank Netter, “The Ciba Collection of Medical Illustrations”, Vol. 3 Digestive System, Part III Liver, Billary Tract And Pancreas (1964). Static testing does not evaluate pancreatic response to stimulation so some pancreatic conditions may not be identified.
For the foregoing reasons, there is a need for a pancreatic test that evaluates pancreatic response to stimulation. Additionally, pancreatic testing in response to stimulation would provide additionally information that would be helpful in selecting a therapy such as electrical stimulation to treat a pancreatic condition and avoid inappropriate therapies, so patients' benefit from decreased risk of medical complications, reduced pain, more rapid treatment, and reduced costs.
SUMMARY OF THE INVENTION
A screening test is used on a patient to determine if pancreatic secretion is responsive to stimulation. The screening test compares measurements of a pancreatic indicator both before and after natural stimulation. The pancreatic indicator is measured before natural stimulation and then the patient's pancreas is naturally stimulated. After waiting a time period from when the natural stimulation began, the pancreatic indicator is once again measured. The difference between the pancreatic indicator measured before ingesting the meal and the pancreatic response indicator measured after ingesting and waiting a time period is calculated and a decision is made whether the patient has a pancreatic condition suitable for treatment with electrical stimulation.
In one version of the invention, an efficacy test is used to evaluate the efficacy of employing electrical stimulation to treat a pancreatic condition. The efficacy test compares a pancreatic response indicator before electrical stimulation and after electrical stimulation to decides whether there is efficacy in using electrical stimulation to treat a patient's pancreatic condition. In other version of the invention, an efficacy test is used to evaluate the efficacy of using electrical stimulation to treat nausea and vomiting.
REFERENCES:
patent: 3719183 (1973-03-01), Schwartz
patent: 4279886 (1981-07-01), Allen
patent: 5188104 (1993-02-01), Wernicke et al.
patent: 5231988 (1993-08-01), Wernicke et al.
patent: 5263480 (1993-11-01), Wernicke et al.
patent: 5425751 (1995-06-01), Baeten et al.
patent: 5699739 (1997-12-01), Brasile et al.
patent: 5716392 (1998-02-01), Bourgeois et al.
patent: 5836994 (1998-11-01), Bourgeois
patent: 5861014 (1999-01-01), Familoni
patent: 5919216 (1999-07-01), Houben et al.
patent: WO 88/03389 (1988-05-01), None
Chen et al., Serosal and Cutaneous Recordings of Gastrc Myoelectrical Activity in Patients with Gastroparesis, Jan. 1994, American Journal of Physiology, vol. 266, Pt. 1, p90-98.*
Richins, “the Innervation of the Pancreas,” J. Comp. Neurol 82:223-236 (1945).
Netter, Frank, “The Ciba Collection of Medical Illustrations,” vol. 3 Digestive System, Part III Liver, Billary Tract and Pancreas (1964).
Kang, Sharon Y., et al., “Pancreatic Exocrine-Endocrine Interrelationship, Clinical Implications”, Pancreas Update 0889-8553 (Sep., 1999), vol. 28, No. 3.
Holst, Jens et al., “Nervous Control of Pancreatic Secretion in Pigs”, Acta Physiol. Scand. 105, 33-51 (1979).
Fiorucci et al., “Duodenal Osmolality Drives Gallbladder Emptying in Humans, Digestive Diseases and Sciences”, vol. 35. No. 6, pp. 698-704 (Jun. 1990).
Koch, Kenneth et al., Electrogastrography, An Illustrated Guide to Gastrointestinal Motility 2ndEd., pp. 290-307 (1993).
McCrosky David
Medtronic Inc.
Winakur Eric F.
Woods Thomas F.
LandOfFree
Pancreatic secretion response to stimulation test protocol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pancreatic secretion response to stimulation test protocol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pancreatic secretion response to stimulation test protocol will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3038703